Garland J. Scott 4
4 · Enliven Therapeutics, Inc. · Filed Jan 9, 2026
Insider Transaction Report
Form 4
Garland J. Scott
Director
Transactions
- Award
Stock Option (right to buy)
2026-01-07+59,372→ 59,372 totalExercise: $15.47Exp: 2036-01-07→ Common Stock (59,372 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option will vest on February 7, 2026 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date.